CD4 and rheumatoid arthritis: Andrade et al. [23] reported that one RA patient treated with MTX and TNF inhibitor (etanercept) showed CD4+ CD8+ TCL with HLH and scattered EBV+ cells and received prompt chemotherapy, remaining alive at 24 months.